| Literature DB >> 32251547 |
Mareike Lembke1, Thomas Höfler1, Ada-Natsuko Walter1, Sarah Tutz1, Vera Fengler2, Stefan Schild1,3,4, Joachim Reidl1,3,4.
Abstract
Protein-protein interactions (PPIs) are key mechanisms in the maintenance of biological regulatory networks. Herein, we characterize PPIs within ToxR and its co-activator, ToxS, to understand the mechanisms of ToxR transcription factor activation. ToxR is a key transcription activator that is supported by ToxS for virulence gene regulation in Vibrio cholerae. ToxR comprises a cytoplasmic DNA-binding domain that is linked by a transmembrane domain to a periplasmic signal receiver domain containing two cysteine residues. ToxR-ToxR and ToxR-ToxS PPIs were detected using an adenylate-cyclase-based bacterial two-hybrid system approach in Escherichia coli. We found that the ToxR-ToxR PPIs are significantly increased in response to ToxR operators, the co-activator ToxS and bile salts. We suggest that ToxS and bile salts promote the interaction between ToxR molecules that ultimately results in dimerization. Upon binding of operators, ToxR-ToxR PPIs are found at the highest frequency. Moreover, disulfide-bond-dependent interaction in the periplasm results in homodimer formation that is promoted by DNA binding. The formation of these homodimers and the associated transcriptional activity of ToxR were strongly dependent on the oxidoreductases DsbA/DsbC. These findings show that protein and non-protein partners, that either transiently or stably interact with ToxR, fine-tune ToxR PPIs, and its associated transcriptional activity in changing environments.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32251547 PMCID: PMC7496328 DOI: 10.1111/mmi.14510
Source DB: PubMed Journal: Mol Microbiol ISSN: 0950-382X Impact factor: 3.501
FIGURE 1ToxS and ompU operator binding sites are key players in ToxR PPIs in E. coli. PPIs of the indicated ToxR and ToxS‐FLAG variants were tested in E. coli W3110 ∆cyaA using a bacterial cAMP‐based two‐hybrid system (BACTH), which is based on the functional complementation of the adenylate cyclase CyaA (Karimova et al., 1998). Strains are N‐terminal ToxR, ToxRW76R and ToxS‐FLAG translational fusions linked to the C‐termini of the B. pertussis CyaA T18 or T25 domains with or without V. cholerae ompU operator fragments (op), and co‐expressed ToxS (a, b). The leucine zipper of the yeast GCN4 protein (zip) was used as a positive complementation control (+), while the empty plasmids pKT25 and pUT18C served as negative controls (‐) (e, f). For the drop test (c, d, e), strains were grown in LB overnight and subsequently transferred to a single MacConkey maltose indicator plate to reveal the CyaA+ phenotype (red colonies indicate the utilization of maltose as a C‐source). PPIs are shown between the indicated ToxR or ToxRW76R translational fusions (designated as X) in the presence or absence of co‐expressed ToxS and ompU operator binding sites (opompU) (c). Panel (d) displays PPIs between ToxR and ToxS‐FLAG (designated as Y). Panel (f) shows quantifications of functional complementation between the indicated ToxR, ToxRW76R and ToxS‐FLAG hybrid proteins (white bars) in dependence of ompU operator binding sites (opompU, lined white bars) by measuring β‐galactosidase activities. The cells were grown in LB supplemented with 0.05 mM IPTG to the stationary phase. Strains in which ToxR and ToxRW76R PPIs were measured in the presence of co‐expressed ToxS were labeled with ToxRS or ToxRW76RS. Strains in which interactions between ToxR and ToxS‐FLAG were analyzed were labeled with ToxR + ToxS‐FLAG. The positive and negative controls are represented by black bars. The values are means of three biological replicates, each with technical triplicates with error bars, which represent the standard deviation. Interactions are reported as Miller Units. The asterisks indicate significantly different means with p < .05 for the respective columns, each tested against E. coli W3110 ∆cyaA pKT25‐ToxR pUT18C‐ToxR or pKT25‐ToxRW76R put18C‐ToxRW76R using one‐way ANOVA test with Bonferroni post hoc analysis [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 2Bile salts (DC) stimulate ToxR PPIs in a ToxS dependent manner. PPIs of ToxR with or without co‐expressed ToxS were tested in dependence of bile salts in E. coli W3110 ∆cyaA using BACTH (Karimova et al., 1998). See experimental procedures for details. The leucine zipper of the yeast GCN4 protein (zip) was used as a positive complementation control (+), while the empty plasmids pKT25 and pUT18C served as negative controls (‐). Cells were grown in LB supplemented with 0.05 mM IPTG to the stationary phase in the absence or presence of 0.1% DC (sodium deoxycholate). The functional complementation of the controls (black bars) and ToxR with or without ToxS (white bars) was quantified by measuring β‐galactosidase activities. DC treated samples are indicated by lined bars. The values are means of three biological replicates, each with technical triplicates with error bars, which represent the standard deviation. The controls contain five values each. Interactions are reported as Miller Units. The asterisks indicate significantly different means with p < .05 using Student's t‐test
FIGURE 3Cysteine dependent homodimer formation in ToxR. V. cholerae ΔtoxRS strains carrying toxR derivatives with or without its operon partner toxS on pFLAG‐MACTM were grown in LB. Samples were taken after 2 hr induction with 0.05 mM IPTG in the mid‐log phase and analyzed by immunoblotting using anti‐FLAG antibodies. Immunoblots were carried out under standard non‐reducing Laemmli buffer conditions
FIGURE 4Transcription factor activity of toxR cysteine mutants. Shown are reporter gene activities of alkaline phosphatase PhoA (Miller Units) linked as operon fusions to either (a) ompU (white bars) or (b) ompT (black bars) in V. cholerae ΔdegP strains harboring various chromosomal cysteine mutations in toxR. Simultaneously, immunoblot analysis was performed under standard reducing Laemmli buffer conditions to detect OmpU or OmpT, respectively. Cells were grown in M9 maltose minimal medium and samples were taken in the mid‐log phase. V. cholerae ΔtoxR served as a negative control. The mean values with standard deviation are shown (n = 6). The asterisks indicate significantly different means with p < .05 for the respective columns each tested against ΔdegP toxR using one‐way ANOVA test, followed by Dunnett's post hoc test for multiple comparisons. To note, all the characterized strains featured a chromosomally toxS background
FIGURE 5DNA binding triggers ToxR homodimer formation. (a) Shown is ToxR immunoblot analysis of V. cholerae WT, ΔtoxR, toxR, toxR, and toxR grown in M9 maltose minimal medium until the mid‐log phase was reached. Immunoblotting was performed under standard non‐reducing Laemmli buffer conditions using anti‐ToxR antibodies. (•) Represents nonspecific cross‐reacting background bands. (b) The column bar graph displays the protein band intensities of ToxR monomers (black bars) and homodimers (white bars) in V. cholerae toxR compared to toxR as a result of densitometric analysis carried out under non‐reducing Laemmli buffer conditions (see representative immunoblot Figure S5a). Here, ToxR protein band intensities were measured per strain (both intensities add up to 100%) using Image Lab Software (BIO‐RAD). The mean values with standard deviation are shown (n = 6). The asterisks indicate significantly different means between toxR and toxR monomers and homodimers with p < .05, respectively, using Student's t‐test. To note, all the characterized strains featured a chromosomally toxS background
FIGURE 6Dsb proteins influence ToxR inter‐ and intramolecular disulfide bond formation and its activity. V. cholerae strains harboring dsbA, dsbC and/or toxR mutations were grown in M9 maltose minimal medium until the mid‐log phase was reached. For ΔtoxRS strains carrying FLAGtoxRS on pBAD18‐Kan or pBAD18, samples were taken after 2 hr of induction with 0.1% arabinose when the cells reached the mid‐log phase. Immunoblotting was performed under standard non‐reducing Laemmli buffer conditions using anti‐ToxR (a) or anti‐FLAG antibodies (d); or reducing conditions using anti‐OmpU (b) or anti‐OmpT antibodies (c). (•) Represents nonspecific cross‐reacting background bands. It is to note, that Kang‐gel staining was performed to provide similar protein levels of all samples shown (Figure S6a,b). To note, all the characterized strains featured a chromosomally toxS background, except for the ΔtoxRS strain used
FIGURE 7Activation mode and interaction patterns of ToxRS. Integral membrane proteins such as ToxRS are inserted into the cytoplasmic membrane co‐translationally, whereby ToxR exposes its reduced cysteine residues to the periplasm. These cysteines are then oxidized by DsbA to form intramolecular disulfide bonds, which represent the proteolytically stable form of ToxR. Increased ToxR‐ToxR PPIs can be detected if ToxS and ToxR‐boxes (e.g., ompU promoter) are available. Such an interaction is further strengthened in the presence of bile (sodium deoxycholate). As a model, we suggest that while ToxR molecules are bound to their operator sequences (ToxR‐boxes), temporarily formed ToxR dimers may exist due to intermolecular disulfide bond formation depending on DsbC or other mechanisms [Colour figure can be viewed at wileyonlinelibrary.com]
Strains and plasmids used in this study
| Strains/Plasmids | Descriptions | References |
|---|---|---|
|
| ||
| DH5αλpir |
| Hanahan, ( |
| SM10λpir |
| Miller and Mekalanos ( |
| XL1‐Blue |
| Bullock |
| BL21 (DE3) |
| NEB |
| W3110 Δ | F‐ λ‐
| Herbst |
|
| ||
| WT | P27459‐S, O1 Inaba, El Tor, clinical isolate, Bangladesh 1976, spontaneous Smr | Pearson |
| Δ | P27459‐S with deletion in | Fengler |
| Δ | P27459‐S with deletion in | Fengler |
|
| P27459‐S with | Fengler |
|
| P27459‐S with | This study |
|
| P27459‐S with | This study |
|
| P27459‐S with | This study |
| Δ | P27459‐S with | Fengler |
|
| P27459‐with | Fengler |
| Δ | P27459‐S Δ | This study |
|
| P27459‐S | This study |
| Δ | P27459‐S with | This study |
| Δ | P27459‐S Δ | This study |
| Δ | P27459‐S with deletion in | This study |
| Δ | P27459‐S Δ | This study |
| Δ | P27459‐S Δ | This study |
| Δ | P27459‐S Δ | This study |
| Δ | P27459‐S Δ | This study |
| Δ | P27459‐S with deletion in | This study |
| Δ | P27459‐S Δ | This study |
| Δ | P27459‐S Δ | This study |
| Δ | P27459‐S Δ | This study |
| Plasmids | ||
| pKEK229 | OriR6K, | Correa |
| pCVD442 | OriR6K, | Donnenberg and Kaper ( |
| pGP704 | OriR6K, | Miller and Mekalanos ( |
| pBAD18‐Kan | Expression vector, oriColE1, arabinose Inducible, Kmr | Guzman |
| pBAD18 | Expression vector, oriColE1, arabinose Inducible, Apr | Guzman |
| pACYC184 | Cloning vector, orip15A, Tetr, Cmr | Rose ( |
| pFLAG‐MACTM | Expression vector with N‐terminal FLAG‐Tag, IPTG inducible, Apr | Sigma‐Aldrich |
| pKT25 | Expression vector, encodes for the first 224 AA of CyaA (T25 fragment, | Karimova |
| pUT18C | Expression vector, encodes for AA 225 to 399 of CyaA (T18 fragment, | Karimova |
| pKEK229dsbA::km | pKEK229 carrying up and down fragments, Apr, Kmr | Fengler |
| pCVD442degP::cat | pCVD442 carrying up and down fragment of | Vorkapic |
| pCVD442toxR | pCVD442 carrying up and down fragment of | Fengler |
| pCVD442FLAGtoxRCC | pCVD442 carrying up and down fragment of FLAGtoxRC236C293S, Apr | Fengler |
| pCVD442FLAGtoxRC236S | pCVD442 carrying up and down fragment of FLAGtoxRC236S, Apr | This study |
| pCVD442FLAGtoxRC293S | pCVD442 carrying up and down fragment of FLAGtoxRC293S, Apr | This study |
| pCVD442FLAGtoxRC293SW76R | pCVD442 carrying up and down fragment of FLAGtoxRC293SW76R, Apr | This study |
| pFLAGtoxR |
| Fengler |
| pFLAGtoxRS |
| Fengler |
| pFLAGtoxRCC |
| Fengler |
| pFLAGtoxRCCtoxS |
| Fengler |
| pFLAGtoxRC236S |
| This study |
| pFLAGtoxRC293S |
| This study |
| pFLAGtoxRW76RS |
| This study |
| pBAD18‐KanFLAGtoxRS | FLAG‐ | This study |
| pBAD18‐FLAGtoxRS | FLAG‐ | This study |
| pGP704dsbC | pGP704 carrying internal fragment of | Fengler |
| pGP704phoAompU | pGP704phoA with | Lembke |
| pGP704phoAompT | pGP704phoA with | Lembke |
| pKT25‐zip | BACTH positive control, leucine zipper of GCN4 (yeast) fused to the T25 fragment, Kmr | Karimova |
| pUT18C‐zip | BACTH positive control, leucine zipper of GCN4 (yeast) fused to the T18 fragment, Apr | Karimova |
| pKT25toxR |
| This study |
| pKT25toxRS |
| This study |
| pKT25toxRW76R |
| This study |
| pKT25toxRW76RS |
| This study |
| pUT18CtoxR |
| This study |
| pUT18CtoxRS |
| This study |
| pUT18CtoxRW76R |
| This study |
| pUT18CtoxRW76RS |
| This study |
| pUT18CtoxSFLAG |
| This study |
| pUT18CopompU |
| This study |
| pUT18CopompU toxR |
| This study |
| pUT18CopompU toxRS |
| This study |
| pUT18CopompU toxRW76R |
| This study |
| pUT18CopompU toxRW76RS |
| This study |
Oligonucleotidesa (5ʹ‐3ʹ) used in this study
| Oligonucleotides (5′‐3′) used in this study | |
|---|---|
| BACTH | |
| Pst_pKT25_ToxR_fwd_BACTH | ATT |
| Pst_pUT18C_ToxR_fwd_BACTH | ATT |
| XbaI_ToxR_rev_BACTH | ATT |
| ToxS_XbaI‐fwd | TAA |
| ToxS‐FLAG_EcoRI‐rev | TAT |
| XbaI_ToxS_rev | ATT |
| BamHI_ompUO123_fwd | ATT |
| KpnI_ompUO123_rev | AAA |
|
| |
| HindIII_toxR_5ʹ_FLAG | AAT |
| KpnI_toxR_3ʹ_FLAG | AAT |
| KpnI_toxR293S_3ʹ_FLAG | AAT |
| toxRC236S_5ʹ | GGCTACCGTCAATCGAAC |
| toxRC236S_3ʹ | TCATTGTATTTTTTAACGC |
| SacI_toxRS_1 | TTT |
| XbaI_toxRS_4 | TTT |
| c_FLAGtoxR_3ʹ_F1 | TGTCATCGTCGTCCTTGTAGTCCATCTAATGTCCCAGTATCTCCCTGT |
| c_FLAGtoxR_5ʹ_F2 | GGGACAGGGAGATACTGGGACATTAGATGGACTACAAGGACGACGATGA |
| c_FLAGtoxR_3ʹ_F2 | CTACTCACACACTTTGATGGCAT |
| c_FLAGtoxRC293S_3ʹ_F2 | CTACTC |
| c_FLAGtoxR_5ʹ_F3 | AACCAGTTAACGCTGAATTACATTC |
| c_FLAGtoxRC293S_5ʹ_F3 | GTTGCTAACCCTAACGATGCCATCAAAGTG |
|
| |
| F1_ToxRC293S‐W76R_XbaI_fwd | TTA |
| F1_SOE_ToxRC293S‐W76R_rev | TTGCTCTCG |
| F2_SOE_ToxRC293S‐W76R_fwd | GACTTTGTT |
| F2_ToxRC293S‐W76R_SacI_rev | TAA |
| pBAD18‐KanFLAGtoxRS, pBAD18‐FLAGtoxRS, pFLAGtoxRW76RS | |
| fwd_SacI_pFlagMAC_ShineD | TTA |
| FLAGtoxR_fw_KpnI | ATA |
| BglII_toxRS_3ʹFLAG | TTA |
| Sequencing | |
| phoA‐seq‐rev | GCTCACCAACTGATAACCAC |
| SacIDsbA1 | TTT |
| Kan_cassette_rv | TTAGAAAAACTCATCGAGCA |
| PhoA3ʹ 180 rev | GCTAAGAGAATCACGCAGA |
| pGP704_CVD_rv|15 | GATGTAACGCACTGAGAAG |
| pBAD_fwd | CCATAGCATTTTTATCCATAAG |
Restriction sites are underlined. Bold letters indicate codons changed to obtain desired amino acid mutations.